<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="120980">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01862471</url>
  </required_header>
  <id_info>
    <org_study_id>EE-NMES-DVT-012</org_study_id>
    <nct_id>NCT01862471</nct_id>
  </id_info>
  <brief_title>Neuromuscular Electrical Stimulation Versus Intermittent Pneumatic Compression for Blood Flow</brief_title>
  <official_title>Improved Lower Limb Haemodynamics Using Neuromuscular Electrical Stimulation (NMES); Potential Novel DVT Prophylaxis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University of Ireland, Galway, Ireland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Irish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National University of Ireland, Galway, Ireland</source>
  <oversight_info>
    <authority>Ireland: Irish Medicines Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep Vein Thrombosis (DVT) is a life threatening condition and a serious concern among
      hospitalized patients, with death occurring in approximately 6% of cases. It involves the
      formation of a clot where stagnant blood flow occurs, predominantly in the deep veins of the
      legs. Three mechanisms underlie DVT, venous stasis (slowing or stopping of the blood),
      hypercoagulability (increased clotting) and damage to blood vessel endothelium (damage to
      blood vessel wall), collectively known as Virchow's triad.

      Intermittent pneumatic compression (IPC) and neuromuscular electrical stimulation (NMES)
      have been shown to improve lower limb blood flow. However, few studies have directly
      compared the two methods and those that have, have used outdated NMES devices.

      The objective of this study is to compare the effectiveness of a modern NMES device to
      intermittent pneumatic compression in terms of blood flow.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Blood Flow Measurements from the Lower Limb</measure>
    <time_frame>An hour and a half (plus or minus half an hour)</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>An hour and a half (plus or minus half an hour)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>An hour and a half (plus or minus half an hour)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Venous Thrombosis</condition>
  <arm_group>
    <arm_group_label>DVT prophylaxis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neuromuscular electrical stimulation using a custom-built, two-channel stimulator (Duo-STIM (stimulator), Bioelectronics Research Cluster, National University of Ireland, Galway) with a frequency of 36 Hz, a balanced biphasic waveform with a pulse width of 350μs, a ramp up time of 500ms, a contraction time of 1s and a ramp down time of 500ms. Stimulation was applied every 20 seconds over a period of 5 minutes.
Intermittent pneumatic compression using the Novamedix A-V Impulse System Model 6000 (Novamedix distribution Limited, England), programmed to deliver compression every 20 seconds at a pressure of 130 mmHg for a 1 second duration over a period of 5 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular Electrical Stimulation</intervention_name>
    <description>Frequency of 36Hz, a balanced biphasic waveform with a pulse width of 350μs, a ramp up time of 500ms, a contraction time of 1s and a ramp down time of 500ms.</description>
    <arm_group_label>DVT prophylaxis</arm_group_label>
    <other_name>Custom-built, two-channel stimulator (Duo-STIM, Bioelectronics Research Cluster, NUI Galway)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intermittent Pneumatic Compression</intervention_name>
    <description>Programmed to deliver compression every 20 seconds at a pressure of 130mmHg for a 1 second duration over a period of 5 minutes.</description>
    <arm_group_label>DVT prophylaxis</arm_group_label>
    <other_name>Novamedix AV Impulse System Model 6000 (Novamedix distribution Limited, England)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -

        Exclusion Criteria:

          -  History of heart/respiratory problems

          -  Pregnancy

          -  Presence of implants, including cardiac pacemakers and orthopaedic implants

          -  History of neurological disorder

          -  History of severe arterial disease or known dermatological problems

          -  Under 18 years of age or over 40 years of age
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gearoid OLaighin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University of Ireland Galway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National University of Ireland, Galway</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 19, 2013</lastchanged_date>
  <firstreceived_date>May 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National University of Ireland, Galway, Ireland</investigator_affiliation>
    <investigator_full_name>Gearoid O Laighin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Deep Vein Thrombosis</keyword>
  <keyword>Neuromuscular Electrical Stimulation</keyword>
  <keyword>Intermittent Pneumatic Compression</keyword>
  <keyword>Doppler Ultrasound</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
